Steve Yoder, director of business developement for pharmaceuticals at TruTag Technologies will lead the talk "Going Beyond the Package: What's Next in Pharmaceutical and Food Security" on Nov. 19 at the Active & Intelligent Package Industry Association World Congress in Utrecht.
Product security concerns are likely to increase demand for technologies such as holograms, according to a press release issued by the International Hologram Manufacturers Association (IHMA).
“Anti-counterfeiting technologies will grow as the criminal masterminds get more sophisticated every year, and the security printing industry needs to expand capabilities using multiple technologies to remain ahead,” stated Ian Lancaster, the general secretary of IHMA, in a news release.
A Swedish company specializing in medical-cosmetic products is making it harder for counterfeiters to copy its anti-wrinkle product, Restylane. Q-Med AB – wholly-owned by Galderma, a pharmaceutical company focusing exclusively on dermatology – protects the health of Chinese customers with a special security seal provided by Pharmapack North America exhibitor Schreiner MediPharm that bears an encrypted code and further counterfeit-protection features.
In an effort to enhance and protect brands, Rollprint Packaging Products Inc. has developed a color-changing sealant for heat-seal applications. The coextrusion-coated sealant can be applied to any thermally stable web such as polyester, nylon, and polypropylene or on any of Rollprint’s ClearFoil barrier structures.
Using the new sealant, medical device and pharmaceutical manufacturers can color code products by type or size. Because the web remains transparent, package contents are visible through the color.
With the rise in counterfeiting and diversion, securing the pharmaceutical supply chain has become even more of a priority. Global standards and country laws are taking shape to establish tracking systems, but investment and consensus are moving slower than the criminals. At Pharmapack North America, speakers and exhibitors will explore emerging requirements as well as voluntary steps companies can take to secure their own supply chains.